Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Arcosa Tightens FY24 Consolidated Revenues Range From $2.58B - $2.78B To $2.60B - $2.72B, Est $2.655B

Author: Benzinga Newsdesk | August 01, 2024 04:57pm
  • Increased the low end of its consolidated Adjusted EBITDA range to $420 million from $410 million, resulting in a full year range of $420 million to $440 million.

Posted In: ACA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist